Introduction
============

*Mycobacterium tuberculosis* is an extremely successful pathogen that has the ability to modulate the host immune response on the level of innate and acquired types.^[@B1],[@B2]^ However, such modulation may be subjected to immunogenetic predisposition because it has been demonstrated that certain human infectious diseases occur more frequently among individuals carrying particular human leukocyte antigen (HLA) alleles.^[@B3]^ HLA-associated susceptibility to infectious disease could be due to the inability of a particular HLA protein to be associated effectively with processed antigens from the pathogen, thereby limiting the capacity of the individual to mount an effective immune response against it.^[@B4]^ Pulmonary tuberculosis (PT) is one of the infectious diseases that follow this manner. In patients with PT, positive associations have been reported between class I and II HLA alleles and the disease in different ethnic populations.^[@B5]^ In this regard, certain HLA alleles (B\*40 and DQB\*0301) and haplotypes (A\*2-DRB1\*1502) are believed to be associated with disease susceptibly,^[@B2],[@B5]-[@B7]^ while a protective effect has also been suggested for other HLA alleles such as A\*11 and B\*57.^[@B5],[@B8]^ It has been concluded accordingly that HLA plays a great role in the pathogenesis of this pathogen.^[@B3],[@B9]^

Consequently, we aimed to study the association between HLA alleles and PT in Iraqi patients, who referred to the Institute of Tuberculosis in Baghdad city.

Patients and Methods
====================

*Subjects*

After obtaining approval from the Iraqi Ministry of Health's Ethics Committee, a total of 105 Iraqi Arab patients of both genders (age range=16-63 years) were enrolled in the study. They referred to the Institute of Tuberculosis (Baghdad) for diagnosis and treatment. The diagnosis was based on clinical symptoms, X-ray chest examination, tuberculin reactivity test, and detection of acid fast bacilli by direct staining of sputum and culture.^[@B10]^ For the purposes of comparison, 40 blood donors, age-, gender-, and ethnicity-matched, were also included and considered as a control group.

*HLA Phenotyping*

Venous blood (10 ml) was drawn in a Heparinized tube, and then it was subjected to a density gradient centrifugation using lymphoprep as a separating medium to collect lymphocytes. The collected cells were further separated into T and B lymphocytes using the nylon wool method. T cells were phenotyped for HLA-class I alleles (A and B), while B cells were employed in the phenotyping of HLA-class II alleles (DR and DQ) in the microlymphocytotoxicity test,^[@B11]^ using a panel of monoclonal antibodies (Biotest Company, Germany) that were able to recognize 8 A, 20 B, 10 DR, and 4 DQ HLA antigens.

*Statistical Analysis*

Significant variations of HLA alleles between the patients and controls were assessed using the Fisher exact probability (P), and the P value was corrected for the number of antigens tested at each locus. The correction factors were 8, 20, 10, and 4 for HLA-A, -B, -DR, and -DQ loci, respectively. The results were presented in terms of observed numbers, percentage frequencies, odds ratio (OR), etiological fraction (EF), and preventive fraction (PF). The latter two estimations were calculated when the OR values were \>1 (positive association) and \<1 (negative association), respectively. The 95% confidence intervals (C.I.) of the OR were also given. The mathematical calculations of these estimations were carried out using the statistical package PEPI, version 4.0.

Results
=======

The observed numbers and percentage frequencies of HLA-class I (A and B) and -class II (DR and DQ) alleles are given in [tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, respectively, while alleles showing significant variations between the PT patients and controls are given in [table 3](#T3){ref-type="table"}. As is shown in the tables, the frequencies of B18 (16.2 vs. 2.5%; OD=7.53) and DR1 (51.4 vs. 10.0%; OD=9.53) alleles were significantly increased in the patients as compared with the controls, while B5 (6.7 vs. 25.0%), DR8 (1.9 vs. 17.5%), and DQ3 (11.4 vs. 45.0%) alleles were significantly decreased. However, a significant corrected level was maintained for only DR1, DR8, and DQ3 alleles (Pc=1.9×10^-5^, 0.02 and 1.0×10^-4^, respectively).

###### 

Observed numbers and percentage frequencies of human leukocyte antigen (HLA)-class I (A and B) alleles in the pulmonary tuberculosis patients and controls

  ---------------------------------------------------------------------------------------------------------------
  **HLA Alleles**   **Pulmonary Tuberculosis Patients (No=105)**   **Controls**\   **P value**          
                                                                   **(No=40)**                          
  ----------------- ---------------------------------------------- --------------- ------------- ------ ---------
  A1                20                                             19.1            7             17.5   0.523

  A2                39                                             37.1            11            27.5   0.001

  A3                20                                             19.1            8             20.0   0.001

  A9                22                                             21.0            13            32.5   0.222

  A10               18                                             17.1            12            30.0   0.395

  A11               10                                             9.5             3             7.5    0.613

  A19               25                                             23.8            5             12.5   0.221

  A28               2                                              1.9             3             7.5    \-\-\--

  B5                7                                              6.7             10            25.0    

  B7                6                                              5.7             5             12.5   0.579

  B8                23                                             21.9            5             12.5   0.057

  B12               7                                              6.7             3             7.5     

  B13               1                                              1.0             4             10.0   \-\-\--

  B14               3                                              2.9             0             0.0    \-\-\--

  B15               1                                              1.0             0             0.0    \-\-\--

  B16               1                                              1.0             0             0.0    \-\-\--

  B17               3                                              2.9             2             5.0    \-\-\--

  B18               17                                             16.2            1             2.5    0.222

  B21               9                                              8.6             3             7.5    0.371

  B22               3                                              2.9             4             10.0   0.371

  B27               1                                              1.0             3             7.5    0.325

  B35               29                                             27.6            6             15.0   \-\-\--

  B37               1                                              1.0             0             0.0    0182

  B40               1                                              1.0             0             0.0    \-\-\--

  B41               11                                             10.5            0             0.0    \-\-\--

  B48               2                                              1.9             1             2.5    \-\-\--

  B53               0                                              0.0             4             10.0   \-\-\--

  B73               1                                              1.0             0             0.0    \-\-\--
  ---------------------------------------------------------------------------------------------------------------

###### 

Observed numbers and percentage frequencies of human leukocyte antigen (HLA)-class II (DR and DQ) alleles in the pulmonary tuberculosis patients and controls

  -------------------------------------------------------------------------------------------------------------
  **HLA Alleles**   **Pulmonary Tuberculosis Patients (No=105)**   **Controls**\   **P value**          
                                                                   **(No=40)**                          
  ----------------- ---------------------------------------------- --------------- ------------- ------ -------
  DR1               54                                             51.4            4             10.0   0.001

  DR2               28                                             26.7            13            32.5   0.028

  DR3               30                                             28.6            6             15.0   0.102

  DR4               28                                             26.7            9             22.5   0.589

  DR5               11                                             10.5            3             7.5    0.242

  DR6               6                                              5.7             3             7.5    0.141

  DR7               14                                             13.3            8             20.0   0.266

  DR8               2                                              1.9             7             17.5   0.005

  DR10              4                                              3.8             3             7.5    0.222

  DR53              6                                              5.7             5             12.5   0.303

  DQ1               32                                             30.5            9             22.5   0.535

  DQ2               24                                             22.9            8             20.0   0.898

  DQ3               12                                             11.4            18            45.0   0.002

  DQ4               9                                              8.6             9             22.5   0.081
  -------------------------------------------------------------------------------------------------------------

###### 

HLA alleles show a significant variation between the pulmonary tuberculosis patients and controls

  **HLA Alleles**   **OR**   **EF or PF**   **P**        **Pc**       **95% C.I**
  ----------------- -------- -------------- ------------ ------------ ---------------
  B5                0.21     0.20           0.004        N.S          0.064-0.69
  B18               7.53     0.14           0.018        N.S          1.093-322.799
  DR1               9.53     0.46           1.9×10^-6^   1.9×10^-5^   3.056-38.922
  DR8               0.09     0.16           0.002        0.02         0.009-0.522
  DQ3               0.16     0.39           2.5×10^-5^   1.0×10^-4^   0.060-0.409

OR: Odds ratio; EF: Etiological fraction; PF: Preventive fraction; P: Fisher's exact probability; Pc: Corrected P; C.I: Confidence interval; N.S: Not significant

Discussion
==========

Several studies have been carried out to understand whether the susceptibility and/or immune response to *M*. *tuberculosis* is associated with HLA phenotype and/or controlled by the genes that are linked to MHC.^[@B8],[@B9],[@B12]^ Studies have also been conducted to find relevant T- cell epitopes of *M*. *tuberculosis* antigens and their peptides in the context of HLA-DR molecules and to define their usefulness for diagnosis or vaccine design.^[@B13]^ For HLA-class I alleles, none of the inspected alleles maintained a significant corrected variation between the patients and controls, although B8 was increased and B5 was decreased in the patients. However, other investigators have reported different positive and negative associations. Hans et al.^[@B14]^ considered A11 and B15 alleles as risk factors for tuberculosis in Americans. On the other hand, Lewinsohn et al.^[@B15]^stated that HLA-B alleles were served as the dominant MHC class I restricting molecules for anti-mycobacterium-specific CD8+ T cell responses measured in CD8+ T cells from patients with PT. These results were in agreement with the previous studies that approved the association between certain HLA types and infectivity and tuberculosis.^[@B16]^ Nevertheless, Vijaya et al.^[@B17]^ suggested that B52 (split of B5) had a negative association (protective effect) with PT, a suggestion that chimes in with the findings of the present study.

The present study also revealed that DR1 was significantly higher in the PT patients than the controls; an observation that may suggest that this allele is a PT predisposing factor in Iraqis, especially when we consider an OR of 9.53 and EF value of 0.46. In contrast, DR8 and DQ3 might be associated with a protective effect. In this regard, it has been demonstrated that an altered memory response to *M*. *tuberculosis* in DR1 negative patients was observed in favor of curing.^[@B18]^ The same authors reported that DR8 was associated with resistance to PT, as was the case in the present study. However, further inconsistent observations have also been documented. DRB1\*1302 phenotype was significantly associated with PT occurring at a significantly higher allele frequency in cases by comparison with controls and especially in haplotype containing DQB1\*0602/3.^[@B19]^ DQB1\*0301-0304 phenotype was also significantly associated with PT, especially when it occurred in haplotype with DRB1\*1101-1121.^[@B9]^ In another study, results indicated that DRB1\*0803 and DQB1\*0601 were found to be associated with PT disease progression, development of drug resistance, and disease severity in Koreans.^[@B20]^ In South Africa, DRB1\*1302 and DQB1\*0301 to -0304 were apparently associated with active PT compared to control individuals lacking these alleles.^[@B3]^ The prevalence of HLA-DRB1\*0401 and HLA-DRB1\*0801 was significantly decreased in Mexican patients with PT compared to their prevalence in healthy controls.^[@B21]^

Conclusion
==========

In Iraqi PT patients, DR1 might be considered as an indicative marker of disease susceptibility, while DR8 and DQ3 are associated with resistance against PT development. However, further studies are required to confirm these associations, and certainly a much clear picture will be gathered if HLA typing is carried out at the molecular level and with a larger number of controls.
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